Safety and effectiveness of brolucizumab in patients with neovascular age-related macular degeneration: A phase IV study from India
Purpose: The purpose of this study is to evaluate the safety and effectiveness of brolucizumab intravitreal injections (IVI) in Indian patients with neovascular age-related macular degeneration (nAMD). Methods: This prospective, interventional, single-arm, open-label phase IV study included 105 trea...
Saved in:
| Main Authors: | Asim K Ghosh, Debdulal Chakraborty, Aditya Sudhalkar, Rohan Chawla, Simar R Singh, Atul K Sahu, Ramesh Venkatesh, Vishal Raval, Sonali Shah, Padma Preetha, Maulik Bhavsar, Sandip Patil, Isha Khadke, Anup Thorat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-06-01
|
| Series: | Indian Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/IJO.IJO_1914_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of neovascular age-related macular degeneration: one year real-life results with intravitreal Brolucizumab
by: Settimio Rossi, et al.
Published: (2025-01-01) -
Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India – Multicentric, real-world study
by: Deependra Vikram Singh, et al.
Published: (2024-12-01) -
Efficacy of Intravitreal Brolucizumab Switch in Pachychoroid Neovasculopathy
by: Nicolò Ribarich, et al.
Published: (2025-07-01) -
Brolucizumab in patients with neovascular age-related macular degeneration: Real-life outcomes from a tertiary care eye hospital
by: Lorenzo Fabozzi, et al.
Published: (2024-11-01) -
Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study
by: Masayuki Ohnaka, et al.
Published: (2025-05-01)